Primary PCL: study identifies independent predictors of survival

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • For patients with primary plasma cell leukemia (pPCL), outcomes may be optimized through upfront autologous stem cell transplantation (ASCT) and novel approaches including proteasome inhibitors and immunomodulators.

Why this matters

  • Data are limited regarding clinical chara...